Feasibility and acceptability of remote smartphone cognitive testing in frontotemporal dementia research

Abstract Introduction Remote smartphone assessments of cognition, speech/language, and motor functioning in frontotemporal dementia (FTD) could enable decentralized clinical trials and improve access to research. We studied the feasibility and acceptability of remote smartphone data collection in FTD research using the ALLFTD Mobile App (ALLFTD‐mApp). Methods A diagnostically mixed sample of 214 participants with FTD or from familial FTD kindreds (asymptomatic: CDR®+NACC‐FTLD = 0 [N = 101]; prodromal: 0.5 [N = 49]; symptomatic ≥1 [N = 51]; not measured [N = 13]) were asked to complete ALLFTD‐mApp tests on their smartphone three times within 12 days. They completed smartphone familiarity and participation experience surveys. Results It was feasible for participants to complete the ALLFTD‐mApp on their own smartphones. Participants reported high smartphone familiarity, completed ∼ 70% of tasks, and considered the time commitment acceptable (98% of respondents). Greater disease severity was associated with poorer performance across several tests. Discussion These findings suggest that the ALLFTD‐mApp study protocol is feasible and acceptable for remote FTD research. HIGHLIGHTS The ALLFTD Mobile App is a smartphone‐based platform for remote, self‐administered data collection. The ALLFTD Mobile App consists of a comprehensive battery of surveys and tests of executive functioning, memory, speech and language, and motor abilities. Remote digital data collection using the ALLFTD Mobile App was feasible in a multicenter research consortium that studies FTD. Data was collected in healthy controls and participants with a range of diagnoses, particularly FTD spectrum disorders. Remote digital data collection was well accepted by participants with a variety of diagnoses.

[1]  K. Papp,et al.  Unsupervised mobile app-based cognitive testing in a population-based study of older adults born 1944 , 2022, Frontiers in Digital Health.

[2]  Jennifer M. Nicholas,et al.  Temporal order of clinical and biomarker changes in familial frontotemporal dementia , 2022, Nature Medicine.

[3]  D. Balota,et al.  Sharper in the morning: Cognitive time of day effects revealed with high-frequency smartphone testing , 2021, Journal of clinical and experimental neuropsychology.

[4]  Timothy A. Miller,et al.  Using Smartphones to Reduce Research Burden in a Neurodegenerative Population and Assessing Participant Adherence: A Randomized Clinical Trial and Two Observational Studies , 2021, JMIR mHealth and uHealth.

[5]  K. Rankin,et al.  Recognition memory and divergent cognitive profiles in prodromal genetic frontotemporal dementia , 2021, Cortex.

[6]  K. Papp,et al.  Current advances in digital cognitive assessment for preclinical Alzheimer's disease , 2021, Alzheimer's & dementia.

[7]  D. Salmon,et al.  A survey of smartphone and interactive video technology use by participants in Alzheimer's disease research: Implications for remote cognitive assessment , 2021, Alzheimer's & dementia.

[8]  Jennifer M. Nicholas,et al.  Impairment of episodic memory in genetic frontotemporal dementia: A GENFI study , 2021, Alzheimer's & dementia.

[9]  K. Rankin,et al.  Uniform data set language measures for bvFTD and PPA diagnosis and monitoring , 2021, Alzheimer's & dementia.

[10]  L. Mangravite,et al.  Evaluating the Utility of Smartphone-Based Sensor Assessments in Persons With Multiple Sclerosis in the Real-World Using an App (elevateMS): Observational, Prospective Pilot Digital Health Study , 2020, JMIR mHealth and uHealth.

[11]  A. Lang,et al.  The Cortical Basal ganglia Functional Scale (CBFS): Development and preliminary validation. , 2020, Parkinsonism & related disorders.

[12]  Jason Holden,et al.  Smartphone-Based Measurement of Executive Function in Older Adults with and without HIV. , 2020, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

[13]  David T. Jones,et al.  Utility of the global CDR® plus NACC FTLD rating and development of scoring rules: Data from the ARTFL/LEFFTDS Consortium , 2020, Alzheimer's & dementia : the journal of the Alzheimer's Association.

[14]  B. Boeve,et al.  Tracking disease progression in familial and sporadic frontotemporal lobar degeneration: Recent findings from ARTFL and LEFFTDS , 2020, Alzheimer's & dementia : the journal of the Alzheimer's Association.

[15]  B. Dickerson,et al.  New directions in clinical trials for frontotemporal lobar degeneration: Methods and outcome measures , 2019, Alzheimer's & Dementia.

[16]  David T. Jones,et al.  The longitudinal evaluation of familial frontotemporal dementia subjects protocol: Framework and methodology , 2019, Alzheimer's & Dementia.

[17]  David T. Jones,et al.  Use of the CDR® plus NACC FTLD in mild FTLD: Data from the ARTFL/LEFFTDS consortium , 2019, Alzheimer's & Dementia.

[18]  J. Kramer,et al.  A longitudinal characterization of perfusion in the aging brain and associations with cognition and neural structure , 2019, Human brain mapping.

[19]  X. Montalban,et al.  Adherence and Satisfaction of Smartphone- and Smartwatch-Based Remote Active Testing and Passive Monitoring in People With Multiple Sclerosis: Nonrandomized Interventional Feasibility Study , 2019, Journal of medical Internet research.

[20]  David T. Jones,et al.  Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH-EXAMINER as a potential clinical trial endpoint , 2019, Alzheimer's & Dementia.

[21]  Suchi Saria,et al.  Using Smartphones and Machine Learning to Quantify Parkinson Disease Severity: The Mobile Parkinson Disease Score , 2018, JAMA neurology.

[22]  J. Smyth,et al.  Reliability and Validity of Ambulatory Cognitive Assessments , 2018, Assessment.

[23]  Jesse A. Brown,et al.  Clinicopathological correlations in behavioural variant frontotemporal dementia , 2017, Brain : a journal of neurology.

[24]  Murray Grossman,et al.  Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria , 2017, Movement disorders : official journal of the Movement Disorder Society.

[25]  Edo Richard,et al.  Cognitive Testing in People at Increased Risk of Dementia Using a Smartphone App: The iVitality Proof-of-Principle Study , 2017, JMIR mHealth and uHealth.

[26]  B. Miller,et al.  Typical and atypical pathology in primary progressive aphasia variants , 2017, Annals of neurology.

[27]  A. Boxer,et al.  Therapy and clinical trials in frontotemporal dementia: past, present, and future , 2016, Journal of neurochemistry.

[28]  S. Friend,et al.  The mPower study, Parkinson disease mobile data collected using ResearchKit , 2016, Scientific Data.

[29]  J. Diehl-Schmid,et al.  The epidemiology of frontotemporal dementia , 2013, International review of psychiatry.

[30]  Nick C Fox,et al.  Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. , 2011, Brain : a journal of neurology.

[31]  Nathaniel Mercaldo,et al.  Development of methodology for conducting clinical trials in frontotemporal lobar degeneration. , 2008, Brain : a journal of neurology.

[32]  C. Basak,et al.  Ageing and Switching of the Focus of Attention in Working Memory: Results from a Modified N-Back Task , 2005, The Quarterly journal of experimental psychology. A, Human experimental psychology.

[33]  P. Glimcher,et al.  Neuroeconomics: The Consilience of Brain and Decision , 2004, Science.

[34]  Nancy La Pelle,et al.  Simplifying Qualitative Data Analysis Using General Purpose Software Tools , 2004 .

[35]  J. Stroop Studies of interference in serial verbal reactions. , 1992 .

[36]  S. Zarit,et al.  Relatives of the impaired elderly: correlates of feelings of burden. , 1980, The Gerontologist.

[37]  E. A. Berg,et al.  A simple objective technique for measuring flexibility in thinking. , 1948, The Journal of general psychology.